MedPath

The effect of 12-week intake of NMN on the sleep and fatigue of community-dwelling older adults

Not Applicable
Conditions
Healthy person
Registration Number
JPRN-UMIN000038097
Lead Sponsor
niversity of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
108
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects with a regular intake of sleeping drugs or anti-depressants(more than once a week) 2) Subjects with an average intake of caffeine more than 400mg per day 3) Subjects with intake of supplements, nutrition drinks or energy drinks that contain NMN or niacin (Vitamin B3, nicotinamide, nicotinic acid amide) 4) Subjects with allergies to supplements, nutrition drinks or energy drinks that contain NMN or niacin(Vitamin B3, nicotinamide, nicotinic acid amide) 5) Subjects diagnosed with chronic fatigue syndrome, sleep disorders(insomnia), mental disorders such as depression, or alcoholism and under medical treatment 6) Subjects who correspond to Not at all in category of fatigue, poor sleep or stress based on 5 level evaluation (Not at all, Slightly, Moderately, Very much, Extremely) 7) Subjects who are involving in other clinical experiments currently or having participated any other clinical experiments in the past 3 months 8) Subjects excluded as inappropriate participants by the lead principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath